COVID-19

Updates on the C19RM Guidelines

26 June 2023

The COVID-19 Response Mechanism (C19RM) Guidelinesdownload in English ] were revised to support applicants to transition C19RM funds toward health systems infrastructure and capacities for pandemic preparedness. Updates have been made in the following areas:

  • Programmatic Priorities:The C19RM Guidelines now reflect the C19RM strategic shift and technical priorities, moving away from addressing a pandemic emergency towards longer-term investments that strengthen health systems and support pandemic preparedness.
  • C19RM Additional Funding Requests: Guidance for C19RM Additional Funding Requests captures changes in (i) endorsement requirements; (ii) submission requirements; and (iii) the review and approval processes.
  • Performance Framework:A C19RM-specific Performance Framework has been introduced and will be required for grants that have received US$20 million or more of C19RM funds. More information on how to integrate the Performance Framework is forthcoming.
  • Key operating principles: Adjustments have been made as to eligible grants for C19RM extension, timelines for using C19RM funds, reinvestment of C19RM 2021 funds, consolidating multiple C19RM grants for extension, and Principal Recipient reporting.
  • Integration of C19RM funds into GC6 grants: Integrating C19RM funds into a grant Implementation Period is done through an additional funding revision and only in GC6 grants (C19RM funding cannot be integrated into GC7 grants). Revisions to integrate C19RM funds must be completed by 30 November 2023 at the latest. If a grant is required to submit a C19RM Grant Performance Framework (mentioned above), an additional revision may be required to incorporate the Performance Framework.
  • Reinvestments of C19RM Funds: The guidance focuses on when countries can demonstrate the shift towards the C19RM strategic priorities.
  • Implementation: Updates have been made to align with the new extension principles.
  • Annex 1 and Risk Management Assurance align with revised sections of the C19RM Guidelines detailed above.